Deep Learning-Based Imbalanced Data Classification for Drug Discovery
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Drug discovery studies have become increasingly expensive and time-consuming processes. In the early phase of drug discovery studies, an extensive search has been performed to find drug-like compounds, which then can be optimized over time to become a marketed drug. One of the conventional ways of detecting active compounds is to perform an HTS (high-throughput screening) experiment. As of July 2019, the PubChem repository contains 1.3 million bioassays that are generated through HTS experiments. This feature of PubChem makes it a great resource for performing machine learning algorithms to develop classification models to detect active compounds for drug discovery studies. However, data sets obtained from PubChem are highly imbalanced. This imbalanced nature of the data sets has a negative impact on the classification performance of machine learning algorithms. Here, we explored the classification performance of deep neural networks (DNN) on imbalance compound data sets after applying various data balancing methods. We used five confirmatory HTS bioassays from the PubChem repository and applied one undersampling and three oversampling methods as data balancing methods. We used a fully connected, two-hidden-layer DNN model for the classification of active and inactive molecules. To evaluate the performance of the network, we calculated six performance metrics, including balanced accuracy, precision, recall, F1 score, Matthews correlation coefficient, and area under the ROC curve. The study results showed that the effect of imbalanced data on network performance could be mitigated to a degree by applying the data balancing methods. The level of imbalance, however, has a negative effect on the performance of the network.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Learning representations by back-propagating errors
Rumelhart, D. E., Hinton, G. E., & Williams, R. J. (1986) · Nature · doi:10.1038/323533a0 · Cited by 31,892
Hinton, G., Deng, L., Yu, D., Dahl, G., Mohamed, A.-R., Jaitly, N., Senior, A., Vanhoucke, V., Nguyen, P., Sainath, T., et al. (2012) · IEEE Signal Processing Magazine · doi:10.1109/msp.2012.2205597 · Cited by 10,260
PubChem Substance and Compound databases
Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv951 · Cited by 5,436
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Virtual screening of chemical libraries
Shoichet, B. K. (2004) · Nature · doi:10.1038/nature03197 · Cited by 1,425
Deep Neural Nets as a Method for Quantitative Structure–Activity Relationships
Ma, J., Sheridan, R. P., Liaw, A., Dahl, G. E., & Svetnik, V. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500747n · Cited by 1,159
DeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081
A Scoring Scheme for Discriminating between Drugs and Nondrugs
Sadowski, J., & Kubinyi, H. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9706776 · Cited by 392
Cited by
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac956 · Cited by 3,443
Deep learning in drug discovery: an integrative review and future challenges
Askr, H., Elgeldawi, E., Aboul Ella, H., Elshaier, Y. A. M. M., Gomaa, M. M., & Hassanien, A. E. (2023) · Artificial Intelligence Review · doi:10.1007/s10462-022-10306-1 · Cited by 390
Adding Stochastic Negative Examples into Machine Learning Improves Molecular Bioactivity Prediction
Cáceres, E. L., Mew, N. C., & Keiser, M. J. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00565 · Cited by 33
Hou, T., Bian, Y., McGuire, T., & Xie, X.-Q. (2021) · Biomolecules · doi:10.3390/biom11060870 · Cited by 30
“In the field of drug discovery, we need to frequently deal with imbalanced datasets [51].”
Background
Metadata
- Authors
- Korkmaz, S.
- Venue
- Journal of Chemical Information and Modeling
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-06-23
- Volume
- 60
- Issue
- 9
- Pages
- 4180-4190
- ISSN
- 1549-9596 (ISSN-L)
- 1549-960X
- OpenAlex
- W3037682562
- Cited by
- 127
- References
- 12
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deep Learning-Based Imbalanced Data Classification for Drug Discovery. https://app.cochat.ai/papers/10.1021/acs.jcim.9b01162
- The paper
- Korkmaz, S. (2020). Deep Learning-Based Imbalanced Data Classification for Drug Discovery. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.9b01162
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.